In patients with NHL, leukemia, multiple myeloma, and melanoma (more so than vitiligo), significantly decreased DPP4 activity and percentages of CD26+ lymphocytes and overall CD26+ white blood cells and lymphocytes have been observed in comparison with healthy individuals. This evidence concerns the gene DPP4 and plasma cell myeloma.